PREGNANCY IN WOMEN WITH CHRONIC KIDNEY DISEASE OF ALL STAGES, INCLUDING WOMEN ON DIALYSIS AND WITH KIDNEY TRANSPLANTS
With
Professor Shilpanjali Jesudason
Head of Unit, Central and Northern Adelaide Renal and Transplantation Service (CNARTS),
Royal Adelaide Hospital,
Central Adelaide Local Health Network (CALHN) &
Clinical Professor, University of Adelaide, South Australia
RESEARCHER PROFILE
Filmed in Adelaide, South Australia | March 2025
Professor Shilpanjali Jesudason is an academic nephrologist and Head of Department at the Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service, South Australia.
From 2017-2020, she was the Clinical Director of Kidney Health Australia, the peak body for patients with kidney disease. In this role she developed a passion for advancing kidney disease education in primary care.
She is the founder and Program Lead for Pregnancy and Kidney Research Australia, co-leads the new ISN Train the Trainer Program for Pregnancy and Kidney Disease, and is the inaugural chair of the Australian and Zealand Dialysis and Transplantation Registry (ANZDATA) Parenthood working group.
She is founding chair of the ANZ Society of Nephrology Pacific Working Group, and has been a supporter of nephrology development in her birth country of Fiji.
In 2025, she was awarded the Roscoe R. Robinson award for outstanding contributions to nephrology, by the International Society of Nephrology.
https://orcid.org/0000-0001-9695-0761
-
Applying nanotechnology to chronic pain management
Dr Felicity Han is a Research Fellow and Leader in Pain Relief Innovation, at the Australian Institute for Bioengineering and Nanotechnology in the University of Queensland. Dr Han’s research interests sit at the interface of drug delivery and the pain field. Her overarching research goal is to improve the quality of day to day life of patients suffering from chronic pain, by applying nanotechnology to the development of novel highly effective pain-killer products for improving chronic pain management.
-
Radiation therapy techniques and combination treatments for sarcoma
Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.
As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.
-
Genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia
Prof Deborah White’s research focus is genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia (ALL) and Chronic Myeloid Leukaemia (CML) and she holds peer reviewed grants from: The William Lawrence and Blanche Hughes Foundation and the Leukemia Lymphoma Society (USA), the NHMRC, the Leukaemia Foundation Australia (LFA), Channel 7, Cancer Australia, Tour de Cure and the Cancer Council SA (CCSA). Professor White has presented more than 170 papers at scientific meetings, and authored more than 100 scientific publications as well as being an inventor on several international patents.
